首页|Central South University Reports Findings in Breast Cancer (Interpretable Machin e Learning Algorithms Identify Inetetamab- Mediated Metabolic Signatures and Biom arkers in Treating Breast Cancer)
Central South University Reports Findings in Breast Cancer (Interpretable Machin e Learning Algorithms Identify Inetetamab- Mediated Metabolic Signatures and Biom arkers in Treating Breast Cancer)
扫码查看
点击上方二维码区域，可以放大扫码查看
原文链接
NETL
NSTL
By a News Reporter-Staff News Editor at Robotics & Machine Learning DailyNews – New research on Oncology - Breast Cancer is the s ubject of a report. According to news reportingoriginating in Hunan, People’s R epublic of China, by NewsRx journalists, research stated, “HER2-positivebreast cancer (BC), a highly aggressive malignancy, has been treated with the targeted therapy inetetamabfor metastatic cases. Inetetamab (Cipterbin) is a recently ap proved targeted therapy for HER2-positivemetastatic BC, significantly prolongin g patients’ survival.”
HunanPeople’s Republic of ChinaAsiaAlgorithmsBiomarkersBreast CancerCancerCyborgsDiagnostics and Screeni ngEmerging TechnologiesHealth and MedicineMachine LearningOncologyTher apyWomen’s Health
NETL
NSTL
